Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ABSI NASDAQ:NUTX NASDAQ:ONMD NASDAQ:UXIN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABSIAbsci$4.77-4.7%$2.91$2.01▼$6.33$720.69M2.064.90 million shs4.64 million shsNUTXNutex Health$104.68-1.3%$95.15$21.44▼$184.27$580.55M-0.2149,558 shs18,652 shsONMDOneMedNet$2.48-10.4%$1.14$0.30▼$4.22$123.83M0.996.34 million shs988,867 shsUXINUxin$3.00-3.2%$3.54$2.72▼$7.48$563.96M1.6106,071 shs50,607 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABSIAbsci+28.21%+19.62%+90.84%+73.61%+25.63%NUTXNutex Health+6.57%+3.18%+10.82%-4.31%+393.76%ONMDOneMedNet-7.67%+20.43%+218.39%+410.13%+304.97%UXINUxin-0.96%-7.46%-6.91%-29.55%-39.92%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABSIAbsci$4.77-4.7%$2.91$2.01▼$6.33$720.69M2.064.90 million shs4.64 million shsNUTXNutex Health$104.68-1.3%$95.15$21.44▼$184.27$580.55M-0.2149,558 shs18,652 shsONMDOneMedNet$2.48-10.4%$1.14$0.30▼$4.22$123.83M0.996.34 million shs988,867 shsUXINUxin$3.00-3.2%$3.54$2.72▼$7.48$563.96M1.6106,071 shs50,607 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABSIAbsci+28.21%+19.62%+90.84%+73.61%+25.63%NUTXNutex Health+6.57%+3.18%+10.82%-4.31%+393.76%ONMDOneMedNet-7.67%+20.43%+218.39%+410.13%+304.97%UXINUxin-0.96%-7.46%-6.91%-29.55%-39.92%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABSIAbsci 2.71Moderate Buy$7.9859.56% UpsideNUTXNutex Health 2.67Moderate Buy$252.50138.19% UpsideONMDOneMedNet 1.00SellN/AN/AUXINUxin 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest ONMD, NUTX, ABSI, and UXIN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/14/2025ONMDOneMedNetWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025ABSIAbsciWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025NUTXNutex HealthWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C-)10/2/2025ABSIAbsciJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight9/27/2025ABSIAbsciWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025NUTXNutex HealthWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C-)9/27/2025ONMDOneMedNetWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)8/26/2025NUTXNutex HealthMaxim GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy$225.00 ➝ $205.008/18/2025ABSIAbsciMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$6.40 ➝ $5.898/13/2025ABSIAbsciNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$9.00 ➝ $8.007/28/2025ABSIAbsciMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$7.00 ➝ $6.40(Data available from 10/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABSIAbsci$4.53M165.03N/AN/A$1.56 per share3.21NUTXNutex Health$479.95M1.23$14.04 per share7.55$37.13 per share2.86ONMDOneMedNet$640K212.68N/AN/A($0.57) per share-4.86UXINUxin$190.40M3.06$51.67 per share0.06($45.07) per share-0.07Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABSIAbsci-$103.11M-$0.94N/AN/AN/A-2,737.94%-60.21%-50.85%11/11/2025 (Estimated)NUTXNutex Health$52.18M$11.898.92∞N/A10.76%42.08%11.80%11/6/2025 (Estimated)ONMDOneMedNet-$10.13M-$0.11N/A∞N/A-728.70%N/A-255.78%N/AUXINUxin-$11.18M-$0.21N/A∞N/A-12.39%N/A-8.81%N/ALatest ONMD, NUTX, ABSI, and UXIN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/11/2025Q3 2025ABSIAbsci-$0.19N/AN/AN/A$1.58 millionN/A11/6/2025Q3 2025NUTXNutex Health-$5.43N/AN/AN/A$221.93 millionN/A9/29/2025Q1 2026UXINUxinN/A-$0.05N/A-$0.05N/A$91.89 million8/13/2025Q2 2025ONMDOneMedNetN/A-$0.03N/A$0.07N/A$0.16 million8/12/2025Q2 2025ABSIAbsci-$0.19-$0.24-$0.05-$0.24$1.39 million$0.59 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABSIAbsciN/AN/AN/AN/AN/ANUTXNutex HealthN/AN/AN/AN/AN/AONMDOneMedNetN/AN/AN/AN/AN/AUXINUxinN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABSIAbsciN/A4.394.39NUTXNutex Health1.022.272.26ONMDOneMedNetN/A0.370.37UXINUxinN/A0.690.26Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABSIAbsci52.05%NUTXNutex Health5.32%ONMDOneMedNet0.95%UXINUxin22.41%Insider OwnershipCompanyInsider OwnershipABSIAbsci10.49%NUTXNutex Health36.92%ONMDOneMedNet44.70%UXINUxin62.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABSIAbsci210149.52 million133.84 millionOptionableNUTXNutex Health1,1505.56 million3.50 millionNot OptionableONMDOneMedNet249.14 million27.18 millionN/AUXINUxin810187.99 million69.74 millionOptionableONMD, NUTX, ABSI, and UXIN HeadlinesRecent News About These CompaniesUxin (NasdaqGS:UXIN) Forecasts 91.61% Annual Revenue Growth Despite Ongoing Losses and High ValuationOctober 16 at 2:48 AM | finance.yahoo.comUxin (NASDAQ:UXIN) Shares Gap Down - Here's WhyOctober 15 at 12:40 PM | marketbeat.comUxin Limited Reports Financial Growth in Interim ResultsOctober 14 at 6:58 PM | msn.comUxin (NASDAQ:UXIN) Sets New 12-Month Low - Here's What HappenedOctober 13 at 1:19 PM | marketbeat.comUxin (NASDAQ:UXIN) Shares Up 5.3% - Here's What HappenedOctober 11, 2025 | marketbeat.comUxin (NASDAQ:UXIN) Sees Strong Trading Volume - Here's WhyOctober 6, 2025 | marketbeat.comWall Street Zen Downgrades Uxin (NASDAQ:UXIN) to SellOctober 5, 2025 | americanbankingnews.comUxin (NASDAQ:UXIN) Stock Rating Lowered by Wall Street ZenOctober 3, 2025 | marketbeat.comUxin Ltd (UXIN) Q2 2025 Earnings Call Highlights: Robust Retail Growth Amidst Expansion ChallengesSeptember 29, 2025 | finance.yahoo.comUxin (NASDAQ:UXIN) Shares Gap Up - Here's WhySeptember 29, 2025 | marketbeat.comUxin Limited (UXIN) Q2 2025 Earnings Call TranscriptSeptember 29, 2025 | seekingalpha.comUxin (NASDAQ:UXIN) Announces Quarterly Earnings ResultsSeptember 29, 2025 | marketbeat.comUxin Reports Unaudited Financial Results for the Quarter Ended June 30, 2025September 29, 2025 | prnewswire.comUxin (NASDAQ:UXIN) Sees Strong Trading Volume - Time to Buy?September 26, 2025 | marketbeat.comUxin Announces Grand Opening of Zhengzhou Used Car SuperstoreSeptember 26, 2025 | prnewswire.comUxin (NASDAQ:UXIN) Shares Up 2.6% - Still a Buy?September 24, 2025 | marketbeat.comUxin to Report Second Quarter 2025 Financial Results on September 29, 2025September 23, 2025 | prnewswire.comUxin (NASDAQ:UXIN) Stock Price Down 7.7% - Should You Sell?September 22, 2025 | marketbeat.comUxin (NASDAQ:UXIN) Shares Up 5.8% - Here's WhySeptember 18, 2025 | marketbeat.comThe Real Experience of Buying a Used Car from Uxin: A Personal Story of Purchasing a CR-V in HefeiSeptember 15, 2025 | sohu.comSUxin to Present at Sidoti September Virtual Investor Conference September 17-18, 2025September 12, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSoundHound Breaks Critical Resistance: How High Can It Get Now?By Thomas Hughes | September 28, 2025The Fed Cut Rates: What Now for the S&P 500 and Equity Markets?By Thomas Hughes | September 18, 2025October’s Top 5 Stocks Poised for Big BreakoutsBy Thomas Hughes | October 1, 2025Why Datavault May Be the Penny AI Stock Investors Have Waited ForBy Nathan Reiff | September 22, 20252 Reasons Absci Could Be the Future of AI Biotech, and 1 RiskBy Nathan Reiff | October 13, 2025ONMD, NUTX, ABSI, and UXIN Company DescriptionsAbsci NASDAQ:ABSI$4.77 -0.23 (-4.68%) As of 11:46 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. The company was founded in 2011 and is headquartered in Vancouver, Washington.Nutex Health NASDAQ:NUTX$104.68 -1.33 (-1.25%) As of 11:45 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.OneMedNet NASDAQ:ONMD$2.48 -0.29 (-10.43%) As of 11:45 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.Uxin NASDAQ:UXIN$3.00 -0.10 (-3.23%) As of 11:45 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Uxin Limited, an investment holding company, engages in the retail sale of vehicles in China. The company operates an e-commerce platform for buying and selling used cars. It also offers used-car acquisition, inspection, reconditioning, warehousing, pre-sales and after-sales, and various car-related value-added products and services, as well as warranty and repair, delivery, and title transfers and vehicle registration services. Uxin Limited was incorporated in 2011 and is headquartered in Beijing, China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Qualcomm: What Last Friday’s Drop Says About Its Q4 Prospects Walmart's AI Play: OpenAI Deal Forges a New Path to Profitability Advanced Micro Devices Eyes $300 as AI Demand Surges From Bulldozers to Big Data: Caterpillar’s Bull Case Gets a Lift Why Analysts Are Upgrading Ratings After Klarna's IPO 3 Healthcare Companies Insiders Are Buying Tempus AI Hits $100—Are Shares Due for a Pullback? Vertiv Stock Surges on Strategic CFO Hire and AI Momentum Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
